Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
John Oyler | Chief Executive Officer | 2025-07-09 | 10,254 | $254.10 | $2.61MSell |
John Oyler | Chief Executive Officer | 2025-07-09 | 9,292 | $253.18 | $2.35MSell |
John Oyler | Chief Executive Officer | 2025-07-09 | 6,703 | $252.23 | $1.69MSell |
John Oyler | Chief Executive Officer | 2025-07-09 | 1,553 | $254.83 | $395.76kSell |
Xiaodong 1. Wang | Director | 2025-06-24 | 507 | $266.57 | $135.15kSell |
Xiaodong 1. Wang | Director | 2025-06-24 | 1,100 | $265.35 | $291.89kSell |
Xiaodong 1. Wang | Director | 2025-06-24 | 300 | $263.50 | $79.05kSell |
Xiaodong 1. Wang | Director | 2025-06-24 | 100 | $267.81 | $26.78kSell |
John Oyler | Chief Executive Officer | 2025-06-23 | 3,074 | $261.57 | $804.07kSell |
Lai Wang | Global Head of RD | 2025-06-23 | 1,028 | $260.00 | $267.28kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Hillhouse Capital Advisors Ltd | 10.48% | 147,035,258 | $37.26B | Insider |
Hhlr Advisors Ltd | 8.91% | 125,045,741 | $31.69B | Insider |
Hillhouse Capital Management Ltd | 7.90% | 110,866,146 | $28.09B | Insider |
Cb Biotech Investment Ltd | 1.40% | 19,601,138 | $4.97B | Insider |
Amgen Inc | 1.35% | 18,943,802 | $4.80B | Insider |
Baker Bros Advisors LP | 0.63% | 8,799,053 | $2.23B | Institution |
Baker Bros Advisors LP | 0.58% | 8,078,829 | $2.05B | Insider |
Merck Co Inc | 0.57% | 7,942,314 | $2.01B | Insider |
John Oyler | 0.56% | 7,914,521 | $2.01B | Insider |
Xiaodong Wang | 0.39% | 5,491,395 | $1.39B | Insider |